1-20 of 337
gemcitabine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Free
Michael S Broder, MD MSHS, Qiufei Ma, PhD, Tingjian Yan, PhD, Eunice Chang, PhD, Lamis K. Eldjerou, MD, Yanni Hao, PhD, David Kuzan, MD, Jie Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4719.
https://doi.org/10.1182/blood-2019-122587
Published: 2019
Journal Articles

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Free
Joshua F Ransom, PhD, Aaron Galaznik, MDMBA, Emelly Rusli, Bruno Lempernesse, MS, Marc Berger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4895.
https://doi.org/10.1182/blood-2019-129086
Published: 2019
Journal Articles

Anti-CD19 CAR T Therapy Following Autologous HSCT May be Safe and Effective in Patients with Refractory Large B-Cell Lymphoma

Free
Wei Liu, Wenyang Huang, Rui Lv, Shuhui Deng, MD, Shuhua Yi, MD, Lugui Qiu, MD PhD, Dehui Zou, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 784.
https://doi.org/10.1182/blood-2019-127659
Published: 2019
Journal Articles

CEOP/IVE/GDP Alternating Regimen Compared with CEOP As the First-Line Therapy for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma: Results from a Phase 2, Multi-Center, Randomized, Controlled Clinical Trial

Free
Mingci Cai, MD, Shu Cheng, MD PhD, Wang Xin, PhD, Jianda Hu, PhD, Yongping Song, Zixun Yan, Yujie Jiang, MD, Xiaosheng Fang, PhD, Xiaoyun Zheng, Lihua Dong, Mengmeng Ji, Li Wang, MD PhD, Pengpeng Xu, Weili Zhao
Journal: Blood
Blood (2019) 134 (Supplement_1): 1556.
https://doi.org/10.1182/blood-2019-122369
Published: 2019
Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Free
Neha Mehta-Shah, MD, Peter A. Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S. Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Jingxia Liu, MS, PhD, Kenneth R. Carson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1550.
https://doi.org/10.1182/blood-2019-124185
Published: 2019
Journal Articles

Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma

Free
Alison J. Moskowitz, MD, Heiko Schoder, MD, Jisun Lee, Theresa Davey, MMSc, PA-C, Helen Hancock, ANP, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, M. Lia Palomba, MD, Gunjan L. Shah, MDMS, Miguel-Angel Perales, MD, Craig S. Sauter, MD, David J. Straus, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 1555.
https://doi.org/10.1182/blood-2019-129364
Published: 2019
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Free
Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

Retrospective EHR Study on Effectiveness of Eltrombopag in Cancer Treatment-Related Thrombocytopenia

Free
Anjali Pawar, MD, Vamsidhar Velcheti, MD, Lincy S. Lal, Lisa Le, Katherine Andrade, Isha Desai, Pallavi Patwardhan, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1100.
https://doi.org/10.1182/blood-2019-124781
Published: 2019
Journal Articles

A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia

Free
Pamela S. Becker, MD PhD, Vivian G. Oehler, MD, Carl Anthony Blau, MD, Timothy S Martins, PhD, Niall Curley, Sylvia Chien, Jin Dai, PhD, Nicole Kauer, Ka Yee Yeung, PhD, Ling-Hong Hung, PhD, Cody Hammer, Paul C. Hendrie, MD PhD, Mary-Elizabeth M. Percival, MD, Ryan D. Cassaday, MD, Bart L. Scott, MD, Roland B. Walter, MD PhD MS, Kelda Gardner, PA-C, Mary Gwin, Heather Smith, PA-C, Andrew Carson, PhD, Bradley Patay, MD, Elihu H. Estey, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1269.
https://doi.org/10.1182/blood-2019-130996
Published: 2019
Journal Articles

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

Free
Paul J. Hampel, MD, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Wei Ding, MD PhD, Eli Muchtar, MD, Saad S. Kenderian, MD, Yucai Wang, MD PhD, Amber Koehler, PA-C, MS, Amie Fonder, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3050.
https://doi.org/10.1182/blood-2019-125411
Published: 2019
Journal Articles

Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Free
Jake R. Schade, BA, Charles Kim, MD, Esther Drill, PhD, Annie Qiu, BA, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Donald Steven Colbourn, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MDMSc, Gottfried R. von Keudell, MD PhD, Anita Kumar, MD, Ariela Noy, MD, Michelle Okwali, MPH, Colette Owens, MD, M. Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, Craig S. Sauter, MD, Heiko Schoder, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Matthew J Matasar, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2904.
https://doi.org/10.1182/blood-2019-122760
Published: 2019
Journal Articles

Case Report: Sustained Remission Achieved from Anti-CD19 CAR T Cell Therapy Despite Prior Treatment with Anti-CD19 Antibody Tafasitamab (MOR208) in a Patient with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Free
Caspian Oliai, MD, Sven de Vos, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5360.
https://doi.org/10.1182/blood-2019-129371
Published: 2019
Journal Articles

R-CHOP Vs. R-CHOP+X for Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Free
Oren Pasvolsky, MD, Alon Rozental, MD, Pia Raanani, MD, Anat Gafter-Gvili, MD, Ronit Gurion
Journal: Blood
Blood (2019) 134 (Supplement_1): 5331.
https://doi.org/10.1182/blood-2019-126013
Published: 2019
Journal Articles

Dual Epigenetic Agents Plus Rituximab-Gemcitabine-Oxaliplatin As a Salvage Treatment in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients

Free
Changju Qu, PhD, Nana Ping, MD, PhD, Danqing Kong, MD, Fan Xia, MD, Depei Wu, MD PhD, Zhengming Jin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5338.
https://doi.org/10.1182/blood-2019-128111
Published: 2019
Journal Articles

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Free
Gerhard Held, MD, Roch Houot, MD PhD, Abraham Avigdor, MD, Marc André, Anna Dabrowska-Iwanicka, Ulrich Jaeger, MD, Sanne Tonino, MD PhD, Marek Trneny, MD prof, Gomes da Silva Maria, MD PhD, Philippe Gaulard, MD PhD, Thierry Jo Molina, MD PhD, Andreas Rosenwald, MD, Grzegorz Rymkiewicz, Thierry Fest, Karin Tarte, PhD, Markus Loeffler, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Viola Poeschel, MD, Corinne Haioun, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5311.
https://doi.org/10.1182/blood-2019-129362
Published: 2019
Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Experience from a Single UK Centre

Free
John Radford, Ellie White, Felipe A. Castro, PhD, Anshuman Chaturvedi, FRCPath, Nathalie Spielewoy, PhD, Adam Gibb, MBBS, Andy Surinach, MPH, Kim Linton, PhD, Aijing Shang, MD PhD, Michael Wenger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2917.
https://doi.org/10.1182/blood-2019-123664
Published: 2019
Journal Articles

Real World Outcomes of Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation and Receive Commercially-Available Salvage Therapy

Free
Emily C. Ayers, MD, David J Margolis, MD, Phyllis A. Gimotty, PhD, Daniel J. Landsburg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2893.
https://doi.org/10.1182/blood-2019-128815
Published: 2019
Journal Articles

Lisocabtagene Maraleucel (liso-cel) for Treatment of Second-Line Transplant Noneligible (TNE) Relapsed/Refractory (R/R) Aggressive Non-Hodgkin Lymphoma (NHL): Initial Results from the PILOT Study

Free
Alison R. Sehgal, MD, John Godwin, John Pribble, Lei Wang, PhD, Jerill Thorpe, BSc, Gerhard C. Hildebrandt, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2882.
https://doi.org/10.1182/blood-2019-127658
Published: 2019
Journal Articles

High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma

Free
Alison J. Moskowitz, MD, Gunjan L. Shah, MDMS, Heiko Schoder, MD, Helen Hancock, ANP, Theresa Davey, MMSc, PA-C, Christopher Joong, BS, Lauren Pomerantz, BS, Christine Jarjies, MS, Anita Kumar, MD, Oscar B Lahoud, MD, Connie Lee Batlevi, MD PhD, Paul A. Hamlin, MD, David J. Straus, MD, Ildefonso Rodriguez-Rivera, MD, Colette Owens, MD, Philip Caron, MD PhD, Donald Steven Colbourn, MD, Andrew M. Intlekofer, MD PhD, Audrey Hamilton, MD, Steven M. Horwitz, MD, Erel Joffe, MDMSc, M. Lia Palomba, MD, Ariela Noy, MD, Matthew J Matasar, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2837.
https://doi.org/10.1182/blood-2019-127575
Published: 2019
Journal Articles

A Randomized Evaluation of Vinorelbine Versus Gemcitabine Chemotherapy Mobilization of Stem Cells in Myeloma Patients

Free
Barbara Jeker, Sarah Farag, Urban Novak, Ulrike Bacher, Behrouz Mansouri Taleghani, Qiyu Li, Thomas Pabst, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1963.
https://doi.org/10.1182/blood-2019-127848
Published: 2019